Oliver Schlager: New ESC and ESVM Clinical Consensus on Lipid-Lowering Therapy in VTE
Oliver Schlager, Head of the Department of Internal Medicine 1 – Angiology at Göttlicher Heiland Hospital Vienna, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:
“Very pleased to share our new Clinical Consensus Document on Lipidlowering Therapy in Venous Thromboembolism of the European Society of Cardiology (ESC) Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Society of Vascular Medicine (ESVM).”
Title: Lipid lowering therapy in venous thromboembolism. A Clinical Consensus Statement of the ESC Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, and the European Society of Vascular Medicine (ESVM)
Authors: Christine Espinola-Klein, Christian Heiss, Marianne Brodmann, Thomas Gary, Lucia Mazzolai, Alessandra Bura-Riviere, Birgit Linnemann, Victor Aboyans, José F Rodriguez Palomares, Frederikus A Klok, Heinz Drexel, Jill Belch, Mislav Vrsalovic, Oliver Schlager

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 12, 2026, 03:54Toby Richards: Representing IronLife at Parliament on Anaemia and Iron Deficiency
-
Sep 12, 2026, 03:50Saleh Shamse Basha: When ‘Low Protein S’ Isn’t Necessarily Low
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy